A method for monitoring a clot dissolution treatment in a patient's vasculature comprises positioning a catheter at a treatment site in the patient's vasculature. The method further comprises performing a clot dissolution treatment at the treatment site. The clot dissolution treatment comprises delivering ultrasonic energy and a therapeutic compound from the catheter to the treatment site such that a clot located at the treatment site at least partially dissolves. The method further comprises delivering a thermal measurement signal from a first portion of the catheter to the treatment site during the clot dissolution treatment. The method further comprises receiving the thermal measurement signal at a second portion of the catheter. The method further comprises comparing the delivered thermal measurement signal with the received thermal measurement signal to evaluate a blood flow rate at the treatment site.

 
Web www.patentalert.com

< Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons

< Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating

> Biocompatible polymer systems carrying triflusal or HTB

> Chemical structure having an affinity for a phospholipid and labeling compound diagnose kit and drug comprising this structure

~ 00231